ZITHROMAXSOLO

Serial Number 78432173
606

Registration Progress

Application Filed
Jun 9, 2004
Under Examination
Feb 7, 2006
Approved for Publication
Oct 26, 2005
Published for Opposition
Nov 15, 2005
Registered

Basic Information

Serial Number
78432173
Filing Date
June 9, 2004
Published for Opposition
November 15, 2005
Abandonment Date
August 8, 2006
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 8, 2006
Classes
005

Rights Holder

Pfizer Inc.

03
Address
235 East 42nd Street
New York, NY 10017

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Christopher N. Bolinger

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

22 events
Date Code Type Description
Oct 12, 2006 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Oct 12, 2006 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Feb 7, 2006 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 15, 2005 PUBO A PUBLISHED FOR OPPOSITION
Oct 26, 2005 NPUB O NOTICE OF PUBLICATION
Sep 29, 2005 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 21, 2005 ACEC I AMENDMENT FROM APPLICANT ENTERED
Sep 21, 2005 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 8, 2005 MAIL I PAPER RECEIVED
Aug 8, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2005 CNFR O FINAL REFUSAL MAILED
Mar 9, 2005 CNFR R FINAL REFUSAL WRITTEN
Feb 15, 2005 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2005 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 26, 2004 ALIE A ASSIGNED TO LIE
Aug 3, 2004 ALIE A ASSIGNED TO LIE
Jul 30, 2004 CPEA F EXAMINER'S AMENDMENT AND/OR PRIORITY ACTION MAILED
Jul 30, 2004 CPEA O EXAMINER'S AMENDMENT AND/OR PRIORITY ACTION MAILED
Jul 29, 2004 CEPE I COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Jul 22, 2004 DOCK D ASSIGNED TO EXAMINER
Jun 16, 2004 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
antibiotic preparation
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Other
The stippling is for shading purposes only.
Pseudo Mark
ZITHROMAX SOLO

Classification

International Classes
005